Status:
UNKNOWN
Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
Mallinckrodt
Conditions:
Liver Transplant
Eligibility:
All Genders
17-70 years
Phase:
PHASE2
Brief Summary
This study is being done to determine if patients receiving (iNO) will have increased liver function and less damage from IR than patients who do not receive (iNO).
Eligibility Criteria
Inclusion
- Liver Transplant
Exclusion
- Living donor transplants
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01172691
Start Date
July 1 2010
End Date
November 1 2015
Last Update
March 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Univsersity Medical Center
Dallas, Texas, United States, 75246